. SiegerLJLongoDL.The control of chemotherapy-induced emesis. Ann Intern Med1981;95:352–9.
2.
. Schulze DelrieuK.Metoclopramide. N Engl J Med1981; 305:28–33.
3.
. StrumSBMcDermedJEOpfellRWRiechLP.Intravenous metoclopramide: an effective antiemetic in cancer chemotherapy. JAMA1982;274:2683–6.
4.
. GrallaRJItriIMPiskoSEAntiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med1981;305:905–9.
5.
. GrallaRJTysonIBClarkRAAntiemetic trials with high-dose metoclopramide: superiority over tetrahydrocannabinol, and preservation of efficacy in subsequent chemotherapy courses. Proc ASCO1982;1:222.
6.
. BrueraEDRocaE.CedaroL.CahconR.EsrevezR.Improved control of chemotherapy-induced emesis by the addition of dexamethasone to metoclopramide in patients resistant to metoclopramide. Cancer Treat Rep1983;67:381–3.
7.
. CraigJ.PowellB.WhiteD.A randomized, crossover comparison of the addition of intravenous lorazepam to metoclopramide and dexamethsone in the prevention of cisplatin-induced emesis. Proc ASCO1986;5:246.
8.
. MeyerBRLewinM.DrayerDEPasmantierM.LonskiL.ReidenbergNN.Optimizing metoclopramide control of cisplatin-induced emesis. Ann Intern Med1984;100:393–5.
9.
. GarnickMB.Oral metoclopramide and cisplatin chemotherapy (letter). Ann Intern Med1983;99:127.
10.
. AnthonyLBKrozelyMGWoodwardNJAntiemetic effect of oral versus intravenous metoclopramide in patients receiving cisplatin: a randomized, double-blind trial. J Clin Oncol1986;4:98–103.
11.
. CarrBIBertrandM.BrowningS.A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: A prospective, randomized, double-blind study. J Clin Oncol1985; 3: 1127–32.
12.
. GrunbergSMGalaKVLampenfeldM.Comparison of the effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized, double-blind crossover study. J Clin Oncol1984;2:782–7.
